Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900 - Test2 - elhamkhani - TriplyDB

Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900

Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900

http://www.wikidata.org/entity/Q26853034

about

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date Dynamic Structure and Inhibition of a Malaria Drug Target: Geranylgeranyl Diphosphate Synthase Global Epidemiology of Plasmodium vivax Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection.The biology of Plasmodium vivax explored through genomics In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9 Clinical and epidemiological aspects of complicated malaria in Colombia, 2007-2013 Management of relapsing Plasmodium vivax malaria Demographic and clinical profiles of Plasmodium falciparum and Plasmodium vivax patients at a tertiary care centre in southwestern India.Performance of loop-mediated isothermal amplification (LAMP) for the diagnosis of malaria among malaria suspected pregnant women in Northwest Ethiopia.Severe Plasmodium vivax infection in Korea.Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants.Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein in Pregnant Women Are Associated with Higher Birth Weight in a Multicenter Study A large scale Plasmodium vivax- Saimiri boliviensis trophozoite-schizont transition proteome.Proteomics of Plasmodium vivax malaria: new insights, progress and potential.Cluster of Imported Vivax Malaria in Travelers Returning From Peru.A model of Plasmodium vivax concealment based on Plasmodium cynomolgi infections in Macaca mulatta Insights into the Cytoadherence Phenomenon of Plasmodium vivax: The Putative Role of Phosphatidylserine.Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite.Are respiratory complications of Plasmodium vivax malaria an underestimated problem?Malaria in India: The Need for New Targets for Diagnosis and Detection of Plasmodium vivax.Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial.Severe thrombocytopaenia in patients with vivax malaria compared to falciparum malaria: a systematic review and meta-analysis.Plasmodium vivax Biology: Insights Provided by Genomics, Transcriptomics and Proteomics.Could Heme Oxygenase-1 Be a New Target for Therapeutic Intervention in Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome?Clinical and Laboratory Features Associated with Acute Kidney Injury in Severe Malaria Manifestation of malaria in Mangaluru, southern India Individualized Transcriptional Resolution of Complicated Malaria in a Colombian Study

P2860

Q26741307-91F55FFB-4DB1-41B2-90CA-7933E38FE30F Q27727743-DBC2B146-BDF2-46BD-A7E3-220246A1FC6E Q30249044-ACCB9097-95F4-4BE3-9942-0D977CB76F3C Q33769314-739F3C62-AE21-4F24-B739-12D98D2EF1C9 Q33860793-D7A39C19-C977-4BB3-B36E-42C2A862D880 Q35513867-ADB71F96-527F-4686-BCA1-31480FFE6A91 Q35898819-45A5F5DA-977F-49BD-B342-C3A6C6BEFC0D Q36890542-EC248FFE-9E0A-4AC3-9444-CD7D3B0F5EDD Q37290599-11111C2F-3BC2-4751-8CBD-2CB54D66FC6C Q37440275-6AC22E87-D935-4D1D-B1BC-618900C1B0E6 Q37593529-7EE1B195-70D7-4EB3-8BF7-FD4552F0509F Q37611096-E8692508-E410-42A9-A702-79FDA618A6B1 Q37627098-380F91BE-2AA7-4943-B7AB-EF1F61B2D8CA Q37647647-89976490-F41B-4630-89E7-EEFC01515202 Q38614192-E7B9C52F-159F-47D9-AEA1-D75CD3048FEF Q38889614-D22B0799-D281-4B6A-A7DA-2C3367BE3F18 Q40556808-474E87C2-0E01-4F3A-80C9-475D4630A375 Q41693116-441BCB7A-8C42-4C00-A1E8-D92873C2A9FE Q41889588-6C5CC131-DDF7-48FC-B580-6051CE203451 Q42699604-CF2F0892-271B-41E2-B442-1B3203707209 Q47144740-8C61F1EB-C541-410F-9E00-3E79B36D5D17 Q47807548-51494274-F77A-4B0C-991D-13A45EDF9BB9 Q48022505-5FF76FFC-8489-4E2D-B860-D4121F248F52 Q48022958-BEBF8A22-91A4-402B-80E7-42BDBE60BBE8 Q49243362-D2C2662E-DCC1-4F4D-AE29-14E906D280E7 Q50225360-F6EEA3FB-F488-447B-B7FD-F7FA5A54C9BB Q55434398-34B8A762-0ECE-4C23-BA0A-2A148D6B482B Q58593083-3F0A1B64-C396-4374-8F1F-3088DB8B3FB8 Q58696227-9E4AD48F-77C8-441D-A9E1-CE3F4220314D Q58738866-E4FC7CCC-888B-4C68-8F73-45A084E17859

P2860

Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900

http://www.wikidata.org/entity/Q26853034

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Severe vivax malaria: a system ...... of clinical studies since 1900

@ast

Severe vivax malaria: a system ...... of clinical studies since 1900

@en

Severe vivax malaria: a system ...... of clinical studies since 1900

@nl

type

label

Severe vivax malaria: a system ...... of clinical studies since 1900

@ast

Severe vivax malaria: a system ...... of clinical studies since 1900

@en

Severe vivax malaria: a system ...... of clinical studies since 1900

@nl

prefLabel

Severe vivax malaria: a system ...... of clinical studies since 1900

@ast

Severe vivax malaria: a system ...... of clinical studies since 1900

@en

Severe vivax malaria: a system ...... of clinical studies since 1900

@nl

P1433

Q26853034-4B24B0D4-4BAC-48C5-B66C-ACF97E371080

P1476

Q26853034-F935C228-9145-408E-8605-FD4F48FD165C

P2093

Q26853034-1160D720-9465-4B65-B3A3-62611B87E202

Q26853034-2E933F4D-D0BD-4358-997E-90E536F0A169

Q26853034-651EF5F2-2974-421F-844A-51EB598D5033

Q26853034-B592086D-A244-4311-8F07-D1B8A89E2055

P275

Q26853034-79DC3121-F2DB-4EFD-A198-63E427B6E5ED

P2860

Q26853034-05A20847-A238-4EBA-87E5-10A1785C2B4E

Q26853034-0C8FCF63-5803-4B89-8F33-8C7DF23293DC

Q26853034-17154812-C548-4659-A3A9-77BA7CBA9A7E

Q26853034-19E74D8D-2C1A-4FC3-B6F4-76F583EB9E09

Q26853034-1DF065D2-7222-480F-B79F-36A0F1804346

Q26853034-1F61B723-90C8-4957-9EAC-F42D0A68DDC4

Q26853034-2FB3D954-09A1-43A3-8056-455A417CB64F

Q26853034-30362587-2923-4B95-9E66-63D06EDAA301

Q26853034-32396931-EA7A-45B1-BDBB-5775F3B60C83

Q26853034-4589847C-46E0-4298-A0A9-7D9C1AE7DFB6

P2888

Q26853034-1EBEA173-70B9-468B-BA94-0699D7BB33B4

P304

Q26853034-CA5DB9ED-A4E7-4C96-B53A-A6322D3D5CD8

P31

Q26853034-757F094C-548C-4A3C-9FBC-2DA645517595

Q26853034-A65D8C2D-38D1-46AB-8873-4EFCF965B1FC

Q26853034-B02D69B3-D45A-408D-A0F5-16083EE05FA3

Q26853034-B5AF7439-224D-432A-BE70-6708E3873775

P3181

Q26853034-21BEE55A-489A-4F9E-B6D6-92464724B249

P356

Q26853034-08F0DC75-AA57-4395-8822-C2E4D2CB3E09

P407

Q26853034-C3B194E8-317F-4C8B-B360-A04FD7907DEC

P478

Q26853034-A69998C4-DF7B-4DE3-BFE3-6CB953B863D9

P50

Q26853034-5112EF1A-E806-47B6-BD4D-DF2363D26461

Q26853034-F94BE6F4-9FCB-497A-B9C7-AEE4E0DE3215

P5008

Q26853034-46D40679-418C-4CA7-86B8-2D6C7068149F

P577

Q26853034-4029956D-43ED-424E-871A-1007EB06D70A

P5875

Q26853034-F67FF8D0-8E19-4E3E-8953-BEE00E5BC5FC

P6179

Q26853034-16949408-2A93-4A36-81C3-7A5639245602

P698

Q26853034-62CAF31C-765D-4533-888D-57CDC55CD182

P921

Q26853034-24663228-2EF2-4F91-A59C-A9F78EE35C0B

Q26853034-A8E14DC7-7232-4804-ADC5-A23FB811501C

Q26853034-E1394292-B931-4570-85A2-18636415839B

Q26853034-F0E7F010-6386-4DDA-ABA5-7B352318F2AD

P932

Q26853034-8B753777-E491-4A7A-BD32-F041843B5146

P3181

P356

1475-2875-13-481

P1433

Malaria Journal

P1476

Severe vivax malaria: a system ...... of clinical studies since 1900

@en

P2093

Ammarin Thakkinstian

http://www.w3.org/2001/XMLSchema#string

Bilal Rahimi

http://www.w3.org/2001/XMLSchema#string

Chukiat Sirivichayakul

http://www.w3.org/2001/XMLSchema#string

Watcharee Chokejindachai

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Evidence and implications of mortality associated with acute Plasmodium vivax malaria

A long neglected world malaria map: Plasmodium vivax endemicity in 2010

The international limits and population at risk of Plasmodium vivax transmission in 2009

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia

Vivax malaria: neglected and not benign

The activation of vivax malaria hypnozoites by infectious diseases.

Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia.

Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua.

Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea.

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.

P2888

1475-2875-13-481

P304

481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

1752164

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1475-2875-13-481

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas John White

P5008

P577

2014-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269467420

http://www.w3.org/2001/XMLSchema#string

P6179

1040780670

http://www.w3.org/2001/XMLSchema#string

P698

25486908

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium vivax malaria

Plasmodium vivax

P932

4364574

http://www.w3.org/2001/XMLSchema#string